SCHEMBL8967704

SCHEMBL8967704

O=c1nc2ccccc2nc2ncccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.46
ALDH1A1 P00352 3/20 0.43
IDO1 P14902 1/20 0.43
HCAR2 Q8TDS4 6/20 0.42
F2 P00734 1/20 0.42
F10 P00742 1/20 0.42
F7 P08709 1/20 0.42
F3 P13726 1/20 0.42
DHODH Q02127 1/20 0.41
PLAUR Q03405 1/20 0.41
KDM4E B2RXH2 2/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
PARP1 P09874 1/20 0.40
GPR3 P46089 1/20 0.39
MIF P14174 1/20 0.39
GABRA1 P14867 1/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2693525 0.89 HCAR2 (0.42) CYP3A4ALDH1A1IDO1HCAR2F2
SCHEMBL1650848 0.87 PLAUR (0.47) CYP3A4ALDH1A1IDO1HCAR2F2
Hydrochloric Acid SCHEMBL5336924 0.85 PLAUR (0.46) CYP3A4ALDH1A1IDO1HCAR2F2
SCHEMBL30276684 0.76 IDO1 (0.38) CYP3A4ALDH1A1IDO1HCAR2F2
SCHEMBL2263391 0.76 PLAUR (0.36) ALDH1A1DHODHPLAURKDM4EMAPT
SCHEMBL2360699 0.74 PLAUR (0.59) ALDH1A1PLAURKDM4EMAPTTSHR
Phenazine SCHEMBL19970688 0.74 MAPT (0.55) CYP3A4ALDH1A1KDM4EMAPTTSHR
SCHEMBL28915934 0.74 MAPT (0.55) CYP3A4ALDH1A1KDM4EMAPTTSHR
SCHEMBL11278490 0.74 EGFR (0.46) CYP3A4ALDH1A1PLAURKDM4EMAPT
SCHEMBL9843434 0.73 HCAR2 (0.41) ALDH1A1IDO1HCAR2F2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
EP-3223821-A1 SUBSTITUTED PYRIDOBENZODIAZEPINONE-DERIVATIVES AND USE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2017-10-04 EP disclosed
EP-3223821-A1 SUBSTITUTED PYRIDOBENZODIAZEPINONE-DERIVATIVES AND USE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2017-10-04 EP disclosed
WO-2016083276-A1 SUBSTITUTED PYRIDOBENZODIAZEPINONE-DERIVATIVES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-06-02 WO disclosed
WO-2016083276-A1 SUBSTITUTED PYRIDOBENZODIAZEPINONE-DERIVATIVES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-06-02 WO disclosed
US-5571809-A The treatment of HIV-1 infection using certain pyridodiazepines BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1996-11-05 US disclosed